alexa Abstract | Synthesis and evaluation of PEGylated amino pyrimidines coated on gold and silver nanoparticles as drug delivery system for anticancer activity

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access

Abstract

A series of PEGylated amino pyrimidines surfaced on to gold and silver nanoparticles was designed, synthesized and evaluated for anticancer activity against three human cancer cell lines: U2OS osteosarcoma, MB231 breast cancer and SW480 colon carcinoma. Non-PEGylated and nanoparticles linked PEGylated pyrimidines exhibited moderate to potent activity against U2OS and MB231. Among them, the PEGylated amino pyrimidines showed excellent broad spectrum activity with IC50 values ranging from 13 to 346μM. Particularly, the PEGylated amino pyrimidines with thiophene ring at C2 showed significant potency against all tested human cancer cell lines. The morphology of all the compounds was tested by TEM and XRD. In this study, two independent approaches that conjugating pyrimidines to PEG(200) and mounting this passive targeting moieties onto the NPs were adopted to fabricate pyrimidine-PEG-AuNPs and pyrimidine-PEG-AgNPs. The NPs synthesized in this study were proven able to effectively target PEGylation to cancer cells, and showed profound apoptotic induction effect to those cells. Although the drug efficacy was compromised after conjugation with Au and Ag, the resultant could still make this moiety NPs a good candidate for anticancer therapy.

To read the full article Peer-reviewed Article PDF image

Author(s): Nitin K Longadge and Anjali M Rahatgaonkar

Keywords

PEG, Nanoparticles, Pyrimidines, anticancer activity, antioxidant activity, PEGylated amino pyrimidines

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords